-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Today, Teyi Pharmaceutical issued an announcement stating that the company had recently obtained the "Metronidazole Tablets" and "Clindamycin Hydrochloride Capsules" approved and issued by the National Medical Products Administration in the "Drug Supplementary Application Approval Notice".
After review, The above-mentioned drugs have passed the quality and efficacy consistency evaluation of generic drugs
.
Drug-related information:
(1) Metronidazole tablets are used to treat and prevent infections identified or suspected to be caused by anaerobic bacteria
.
This product has inhibitory activity against a variety of pathogenic microorganisms, especially Bacteroides, Fusobacterium, Clostridium, Eubacteria, Peptococcus, Peptostreptobacter, Anaerococcus and Gardnerella vaginalis
(2) Clindamycin Hydrochloride Capsules are mainly used for infectious diseases caused by sensitive strains such as Streptococcus, Staphylococcus and anaerobic bacteria, and are widely used clinically in the lower respiratory tract, skin, soft tissue, obstetrics and gynecology, and abdominal cavity Wait for infection